Proteomics Technologies and Markets, 2022 - Technologies, Platform and Software Markets, Disease Markets, Biochip Markets and End-Use Industry Markets

DUBLIN, Sept. 27, 2018 /PRNewswire/ --

The "Proteomics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The study scope covers MS instruments, consumables, workflow products, planar arrays, bead arrays, and LOCs. It also covers the research, drug discovery and development, diagnostics, and applied end-user market segments. The main geographical markets-North America, Europe, Asia-Pacific, and Rest of the World (ROW)-are included.

The MS market is covered by instrument type, MS consumables, and product type and end-user markets. The biochip market is covered by biochip type and the end-user market for each type. The diagnostics market is covered in some detail, including by major platform (i.e., MS, biochips), by disease type and for cancer by indication. This report provides the current market sizes for these segments, as well as their forecasted growth through 2022.

Technology status and forces driving the market are discussed and analyzed. Factors that influence each market are also highlighted, including growth-driving forces, industry alliances and acquisitions, applications in diagnostics and drug discovery, customer needs, and competitive trends.

The two key proteomics technologies - mass spectrometry and biochips - are benefiting from an explosion of new proteomics content from the large-scale genomic and proteomic initiatives. For instance, according to the Journal of Proteome Research, ACS Publications, the Human Proteome Organization (HUPO) has introduced the Proteomics Standards Initiative (PSI) that is exploring software tools and open community standards in proteomics over the last 15 years (from 2002).

Further, HUPO is also credited with completing the protein parts list for the draft human proteome. In addition, HUPO is also exploring the application of proteomics for integration with genomics and transcriptomics across life sciences and biomedical research. This proteomics content is driving the discovery of new biomarkers that are important in disease diagnostic processes such as cancer diagnostics, myocardial infarction, congestive heart failure, and others.

Novel technologies are also driving proteomics applications. For example, increasing miniaturization and integration is occurring in biochip devices and improvements in mass spectrometry workflow and instruments. These innovations are driving proteomics applications in important markets like drug discovery and development and diagnostics. For instance, in 2017, as per the European Association of Urology, the Israeli Institute of Technology developed a silicon biosensor chip that can identify the best antibiotics in just a few hours instead of days and can help in treating a bacterial infection.

Furthermore, in 2017, the Georgia Institute of Technology presented that replacing conventional power supplies with Triboelectric Nano-generators (TENG) for charging molecules can boost up the sensitivity of mass spectrometers and can also help in identification of small volumes.

Key industry acquisitions and strategic alliances are given for the three-year period from 2015 through 2018.

This report also examines the main patent trends within the industry and profiles 108 proteomics companies.

The Report Includes:

• An overview of the global proteomics market, which covers: technologies, platform and software markets, disease markets, biochip markets and end-use industry markets
• Analyses of global market trends, with data from 2016 and 2017, and projections of CAGRs through 2022
• Examination of market trends and opportunities that will impact the future market
• A look at proteomics scientific initiatives, industry acquisitions and patents
• Discussion of proteomic applications in drug discovery and development
• Comprehensive company profiles across subsegments, such as protein chip providers, reagent providers, service providers, informatics and database providers, etc.
• Company profiles of major players, including Abcodia Ltd., Bruker Corp., Digilab Inc., Glaxosmithkline Plc., & Luminex Corp

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Overview

• Proteomic Technologies
• Scope of Report
• Proteomics Market
• Driving Forces for Proteomics Industry Growth
• The Proteomics Industry

Chapter 4 Proteomics Technologies

• Introduction
• MS-Based Proteomics Technologies
• Sample Preparation Assays
• Tagging/Affinity Methods
• Utility of Proteomics to Identify Biomarkers
• MS Instruments and Consumables
• Biochip-Based Proteomics Technologies
• Multiplex Proteomics Systems
• Proteogenomics
• Recent Advances in Proteomics Technologies

Chapter 5 Proteomics Applications in Drug Discovery and Development

• Target Discovery
• Lead Identification
• Lead Optimization
• Preclinical Studies

Chapter 6 Proteomics Scientific Initiatives

Chapter 7 Clinical Proteomics Applications

• Applications in Cancer
• Overview
• Bladder Cancer
• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Kidney Cancer
• Lung Cancer
• Lymphomas
• Ovarian Cancer
• Prostate Cancer
• Thyroid Cancer
• Infectious Diseases
• Diabetes
• Neurological Disorders
• Alzheimer's Disease
• Schizophrenia
• Immune Diseases
• HLA Typing
• Autoimmune Disease
• Cardiovascular Disease
• Preeclampsia

Chapter 8 Proteomics Industry

• Industry Acquisitions
• Industry Strategic Alliances
• Mass Spectrometry Industry
• Chromatography Industry
• Proteomics-Based Drug Discovery and Development Industry
• Proteomics Biochip Industries
• Peptide Microarray Industry
• High-Density Protein Array Industry
• Antibody Microarray Industry
• China's Biochip Industry
• LOC Proteomics Industry
• Chemical Proteomics Industry
• Antibody Reagent Industry
• Multiplex Protein Diagnostics Industry
• Dried Blood Spotting Proteomics Industry
• Single Cell Proteomics Industry

Chapter 9 Proteomics Markets

• Driving Forces of Proteomics Industry Growth
• Global Proteomics Markets
• Market Summary
• Research Market
• Drug Discovery and Development Market
• Proteomics Diagnostic Market
• Mass Spectrometry-Based Proteomics Market
• Biochip-Based Proteomics Market
• Proteomics Geographic Market

Chapter 10 Proteomics Patents

• Protein Array Patents
• Lab-on-a-Chip Patents
• Mass Spectrometry Patents

Chapter 11 Company Profiles

Companies Mentioned

• Abcodia Ltd.
• Ablynx Nv (Acquired By Novo Nordisk)
• Activiomics Ltd.
• Activx Biosciences Inc.
• Advanced Proteome Therapeutics Inc.
• Agilent Technologies Inc.
• Applied Microarrays
• Applied Proteomics
• Arrayit Corp.
• Astute Medical Inc.
• Avacta Group Plc.
• Ayoxxa Biosystems Gmbh
• Bio-Rad Laboratories Inc.
• Bio-Techne Inc.
• Biocartis Nv
• Biodesix Inc.
• Biognosys Ag
• Biomerieux Sa
• Bioproximity Llc
• Bruker Corp.
• Cambridge Protein Arrays Ltd.
• Caprion Biosciences Inc. (Acquired By Gho Capital)
• Caprotec Bioanalytics Gmbh (Acquired By Charles River Laboratories International Inc.)
• Carmenta Bioscience Inc. (Acquired By Progenity Inc.)
• CDI Laboratories Inc.
• Crelux Gmbh
• Crystalgenomics Inc.
• Danaher Corp.
• Diassess
• Digilab Inc.
• Epicypher Inc.
• Evotec Ag
• Fluidigm Corp.
• General Electric Co.
• GL Sciences Inc.
• Glaxosmithkline Plc.
• Global Discovery Biosciences
• Healthtell Inc.
• Hybrigenics Sa
• Immunovia Ab
• Imtakt Corp.
• Indi Molecular
• Integrated Diagnostics
• Iris International Inc. (Acquired By Danaher Corp.)
• Labcyte Inc.
• Leap Technologies Inc. (Acquired By Trajan Scientific And Medical)
• Luminex Corp.
• Merck & Co. Inc.
• Merck Kgaa
• Microlytic (Acquired By Anatrace)
• Mosaiques Diagnostics And Therapeutics Ag
• MRM Proteomics Inc.
• Mycartis
• Myriad Genetics Inc.
• Newomics Inc.
• Nirmidas Biotech Inc.
• Olink Bioscience
• Opko Health Inc.
• Perkinelmer Inc.
• Personalized Cancer Therapy Inc.
• Pfizer Inc.
• Phenomenex Inc.
• Phylogica Ltd.
• Pressure Biosciences Inc.
• Prometic Life Sciences Inc.
• Protagen Ag
• Protea Biosciences Inc.
• Proteocyte Diagnostics Inc.
• Proteogenix
• Proteome Sciences Plc.
• Proteomics International Pty Ltd.
• Proteovista Llc
• Provista Diagnostics Inc.
• Qiagen Nv
• Quansys Biosciences
• Quanterix Inc.
• Quest Diagnostics Inc.
• Repligen Corp.
• Retrogenix Ltd.
• Samdi Tech Inc.
• Sera Prognostics
• Shimadzu Corp.
• Shiseido Company Ltd.
• Showa Denko Kk
• Sigma Aldrich (Acquired By Merck)
• Singulex Inc.
• Siscapa Assay Technologies Inc.
• Somalogic Inc.
• Sphere Fluidics Ltd.
• Spoton Clinical Diagnostics Ltd.
• SQI Diagnostics
• T2 Biosystems
• Theranostics Health (Acquired By Avant Diagnostics)
• Thermo Fisher Scientific Inc.
• Thorne Diagnostics Inc.
• Tosoh Corp.
• Universal Biosensors Ltd.
• Vermillion Inc.
• VG Life Sciences Inc.
• Waters Corp.
• Xencor Inc.
• YMC Co. Ltd.
• Zephyrus Biosciences Inc. (Acquired By Bio-Techne Corp.)

For more information about this report visit https://www.researchandmarkets.com/research/h8bk2t/proteomics?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com